Intracellular pathogens and innate immunity
Intracellular pathogens and innate immunity
批准号:
8507131
负责人:
DANIEL A PORTNOY
金额:
$176.59万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-12-01 至 2016-06-30
关键词:
AdjuvantAdjuvanticityAffectBindingBiochemicalBiochemistryBone MarrowBreedingCellsCommunitiesComputer softwareCytosolDNADataData SetDefectDiseaseEnsureEthylnitrosoureaFocus GroupsFrancisella tularensisFundingGenesGeneticGenetic ScreeningGoalsGrowthHealthIRF3 geneImmuneImmune responseImmune systemImmunityIn VitroInfectionIntegration Host FactorsInterferonsInternationalInvestigationLeadLeadershipLegionella pneumophilaLigandsListeria monocytogenesMapsMethodologyMicrobeModelingMolecularMolecular ModelsMonitorMouse StrainsMusMutagenesisMutationMycobacterium tuberculosisNatural ImmunityNucleic AcidsNucleotidesPathogenesisPathway interactionsPhagosomesPhosphotransferasesPreventionProgram Research Project GrantsProteinsRNAReportingRoleSignal TransductionSignaling MoleculeSystemTBK1 geneTestingTherapeuticTimeType IV Secretion System PathwayVaccinesbiodefensebis(3&apos,5&apos)-cyclic diguanylic acidclinically relevantefflux pumpgenetic analysisglobal healthin vivomacrophagemeetingsmembermicrobialmolecular modelingmutantnovelnucleotide receptorpathogenprogramsresponse
中文摘要
描述(由申请者提供):本申请是一项名为“细胞内病原体和先天免疫”的计划项目资助的竞争性续签,最初资助于2004年,2009年由ARRA提供两年的资助。正在研究的中心问题是细胞内病原体如何被宿主固有免疫系统识别,反之,病原体如何避免和/或操纵宿主反应来促进其发病。该计划由三个项目和两个核心组成。在项目1中,Portnoy建议扩展他的发现,即单核细胞增多性李斯特菌激活宿主胞浆监视途径(CSP),导致干扰素和共同调节基因的表达。在过去的资助期间,细菌配体被鉴定为c-di-AMP,这是一种新发现的小细菌信号分子,似乎是细菌生长所必需的,并通过细菌多药外排泵分泌。我们将探讨c-di-AMP在感染和免疫中的作用。在项目2中,考克斯发现结核分枝杆菌需要ESX-1辅助分泌系统来激活CSP,他建议识别和表征有助于反应的细菌配体(S)和宿主因素。在项目3中,万斯与其他两个小组合作,专注于识别和表征控制CSP的宿主因素。他已经建立了ENU突变程序,并确定宿主蛋白Sting对于单核细胞增多性乳杆菌、结核分枝杆菌、c-di-AMP、c-di-GMP和DNA的反应是必需的。此外,在初步数据中,Sting似乎是环二核苷酸受体。核心B由巴顿管理,是一只小鼠和ENU的核心,将继续产生和繁殖大约25个品系的小鼠,在相关的先天性免疫途径中具有单突变、双突变和三突变。该核心还将管理ENU正向基因筛查,并将潜在的突变巨噬细胞分配给其他项目负责人,以筛查先天免疫途径中的宿主缺陷。核心A的目的是通过提供科学、组织和行政领导来确保科学进步和促进协同作用,这将通过在所有实验室小组每月会议期间对科学进展进行广泛审查来实现。
英文摘要
DESCRIPTION (provided by applicant): This application is a competitive renewal of a Program Project Grant entitled, "Intracellular pathogens and innate immunity," originally funded in 2004 and renewed in 2009 with two years of funding from the ARRA. The central problem under investigation is how intracellular pathogens are recognized by the host innate immune system and conversely, how pathogens avoid and/or manipulate the host response to promote their pathogenesis. The program consists of three projects and two cores. In Project 1, Portnoy proposes to extend his discovery that L. monocytogenes activates a host cytosolic surveillance pathway (CSP) leading to the expression of IFN-¿ and co-regulated genes. During the past funding period, the bacterial ligand was identified as c-di-AMP, a newly discovered small bacterial signaling molecule that appears to be essential for bacterial growth, and is secreted through a bacterial multidrug efflux pump. The role of c-di-AMP during infection and immunity will be explored. In Project 2, Cox found that M. tuberculosis requires the ESX-1 auxiliary secretion system to activate the CSP, and he proposes to identify and characterize the bacterial ligand(s) and host factors that contribute to the response. In Project 3, Vance collaborates with the other two groups and focuses on the identification and characterization of host factors that control the CSP. He has already established a program of ENU mutagenesis and identified that the host protein Sting is necessary for the response to L. monocytogenes, M. tuberculosis, c-di-AMP, c-di-GMP, and DNA. Furthermore, in preliminary data, Sting appears to be the cyclic-di-nucleotide receptor. Core B, managed by Barton, is a mouse and ENU core that will continue to generate and breed approximately 25 strains of mice with single, double and triple mutations in relevant innate immune pathways. The core will also manage the ENU forward genetic screen and dispense potential mutant macrophages to the other project leaders to screen for host defects in innate immune pathways. The purpose of Core A is to ensure scientific progress and promote synergy by providing scientific, organizational, and administrative leadership, which will be accomplished by extensive review of scientific progress during monthly meetings of all the lab groups.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of Listeria cyclic-di-AMP during infection and immunity
-
批准号:8234225
-
项目类别:
-
资助金额:$43.31万
-
财政年份:2011
-
负责人:DANIEL A PORTNOY
-
依托单位:
Listeria-based vaccines engineered to modulate the innate immune system
-
批准号:8296801
-
项目类别:
-
资助金额:$35.51万
-
财政年份:2011
-
负责人:DANIEL A PORTNOY
-
依托单位:
Administrative Core A
-
批准号:8234235
-
项目类别:
-
资助金额:$18.0万
-
财政年份:2011
-
负责人:DANIEL A PORTNOY
-
依托单位:
Project 1: Listeria metabolites and innate immunity
-
批准号:10190578
-
项目类别:
-
资助金额:$49.85万
-
财政年份:2004
-
负责人:DANIEL A PORTNOY
-
依托单位:
Intracellular Pathogens and Innate Immunity
-
批准号:7177234
-
项目类别:
-
资助金额:$5.76万
-
财政年份:2004
-
负责人:DANIEL A PORTNOY
-
依托单位:
Administrative Core A
-
批准号:9977102
-
项目类别:
-
资助金额:$16.55万
-
财政年份:2004
-
负责人:DANIEL A PORTNOY
-
依托单位:
The intersection of innate and adaptive immunity to intracellular pathogens
-
批准号:10655288
-
项目类别:
-
资助金额:$232.54万
-
财政年份:2004
-
负责人:DANIEL A PORTNOY
-
依托单位:
Administrative Core A
-
批准号:10190576
-
项目类别:
-
资助金额:$17.48万
-
财政年份:2004
-
负责人:DANIEL A PORTNOY
-
依托单位:
Project 1: Innate immune responses triggered by Listeria monocytogenes
-
批准号:9977105
-
项目类别:
-
资助金额:$53.08万
-
财政年份:2004
-
负责人:DANIEL A PORTNOY
-
依托单位:
The intersection of innate and adaptive immunity to intracellular pathogens
-
批准号:10400179
-
项目类别:
-
资助金额:$233.32万
-
财政年份:2004
-
负责人:DANIEL A PORTNOY
-
依托单位:
Project 1: Listeria metabolites and innate immunity
-
批准号:10400182
-
项目类别:
-
资助金额:$55.83万
-
财政年份:2004
-
负责人:DANIEL A PORTNOY
-
依托单位:
Intracellular Pathogens and Innate Immunity
-
批准号:7027678
-
项目类别:
-
资助金额:$200.87万
-
财政年份:2004
-
负责人:DANIEL A PORTNOY
-
依托单位:
Intracellular Pathogens and Innate Immunity
-
批准号:7188971
-
项目类别:
-
资助金额:$204.97万
-
财政年份:2004
-
负责人:DANIEL A PORTNOY
-
依托单位:
Manipulation of Host Innate Immunity by Listeria
-
批准号:6880450
-
项目类别:
-
资助金额:$11.64万
-
财政年份:2004
-
负责人:DANIEL A PORTNOY
-
依托单位:
Intracellular pathogens and innate immunity
-
批准号:7860371
-
项目类别:
-
资助金额:$251.71万
-
财政年份:2004
-
负责人:DANIEL A PORTNOY
-
依托单位:
Administrative Core A
-
批准号:10400180
-
项目类别:
-
资助金额:$17.14万
-
财政年份:2004
-
负责人:DANIEL A PORTNOY
-
依托单位:
Intracellular pathogens and innate immunity
-
批准号:8301525
-
项目类别:
-
资助金额:$190.74万
-
财政年份:2004
-
负责人:DANIEL A PORTNOY
-
依托单位:
Intracellular Pathogens and Innate Immunity
-
批准号:6861549
-
项目类别:
-
资助金额:$70.05万
-
财政年份:2004
-
负责人:DANIEL A PORTNOY
-
依托单位:
The intersection of innate and adaptive immunity to intracellular pathogens
-
批准号:10190575
-
项目类别:
-
资助金额:$230.78万
-
财政年份:2004
-
负责人:DANIEL A PORTNOY
-
依托单位:
Intracellular Pathogens and Innate Immunity
-
批准号:6953755
-
项目类别:
-
资助金额:$201.4万
-
财政年份:2004
-
负责人:DANIEL A PORTNOY
-
依托单位:
海外基金